Hypotension and multiple organ dysfunction syndrome

References

• Tilney NL, Bailey GL, Morgan AP. Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care. Ann Surg 1973; 178: 117–22
   PubMed Web of Science ®Google Scholar
• Baue AE. Multiple progressive or sequential system failure: a syndrome of the 1970's. Arch Surg 1975; 110: 779–81
   PubMedGoogle Scholar
• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–55
   PubMed Web of Science ®Google Scholar
• Deitch EA. Multi-organ failure: pathophysiology and potential future therapy. Ann Surg 1992; 216: 117–34
   PubMed Web of Science ®Google Scholar
• Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990's: systemic inflammatory response and organ dysfunction. JAMA 1994; 271: 226–33
   PubMed Web of Science ®Google Scholar
• Marshall JC. Multiple organ dysfunction syndrome (MODS). Clinical trials for the treatment of sepsis, WJ Sibbald, JL Vincent. Springer-Verlag, BerlinGermany 1995; 122–84
   Google Scholar
• Eiseman B, Beart R, Norton L. Multiple system organ failure. Surg Gynecol Obstet 1977; 144: 323–6
   PubMedGoogle Scholar
• Fry DE, Pearlstein L, Fulton RL. Multiple organ system failure: the role of uncontrolled infection. Arch Surg 1980; 115: 136–40
   PubMed Web of Science ®Google Scholar
• Moss M, Parsons PE, Steinberg KP. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 2003; 31: 869–77
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–6
   PubMed Web of Science ®Google Scholar
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–74.
   PubMed Web of Science ®Google Scholar
• Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Klein KL, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997; 278: 234–40
   PubMed Web of Science ®Google Scholar
• Sessler CN, Shepherd W. New concepts in sepsis. Curr Opin Crit Care 2002; 8: 465–72
   PubMedGoogle Scholar
• Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273: 117–23
   PubMed Web of Science ®Google Scholar
• Youkeles LH, Rosen MJ. The epidemiology of sepsis in the immunocompromised host. Sepsis and multiple organ failure, AM Fein, EM Abraham, RA Balk, et al. Williams & Wilkins, Baltimore, MD 1997; 35–42
   Google Scholar
• Aube H, Milan C, Blettery B. Risk factors for septic shock in the early management of bacteremia. Am J Med 1992; 93: 283–8
   PubMedGoogle Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–50
   PubMed Web of Science ®Google Scholar
• Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235–43
   PubMed Web of Science ®Google Scholar
• Evans TW, Smithies M. ABC of intensive care: organ dysfunction. Br Med J 1999; 318: 1606–9
   PubMed Web of Science ®Google Scholar
• Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000; 16: 337–52
   Google Scholar
• Bellingan G. Inflammatory cell activation in sepsis. Br Med Bull 1999; 55: 12–9
   PubMedGoogle Scholar
• Vlessis AA, Goldman RK, Trunkey DD. New concepts in the pathophysiology of oxygen metabolism during sepsis. Br J Surg 1995; 82: 870–6
   PubMedGoogle Scholar
• Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do not know about cytokine regulation. Crit Care Med 1996; 24: 163–72
   PubMed Web of Science ®Google Scholar
• Johnson K, Aarden L, Choi Y, De Groot E, Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87: 5051–60
   PubMedGoogle Scholar
• Pinsky MR, Vincent J-L, Deviere J, Alegre M, Krahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565–75
   PubMed Web of Science ®Google Scholar
• Dettenmeier P, Swindell B, Stroud M, Arkins N, Howard A. Role of activated protein C in the pathophysiology of severe sepsis. Am J Crit Care 2003; 12: 518–24
   PubMed Web of Science ®Google Scholar
• Levi M, de Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 2004; 36: 41–9
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–50
   PubMed Web of Science ®Google Scholar
• Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588–95
   PubMed Web of Science ®Google Scholar
• Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999; 27: 1369–77
   PubMed Web of Science ®Google Scholar
• Vallet B, Tavernier B, Lund N. Assessment of tissue oxygenation in the critically ill. Eur J Anaesthesiol 2000; 17: 221–9
   PubMedGoogle Scholar
• Fink MP. Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001; 17: 219–37
   PubMed Web of Science ®Google Scholar
• De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166: 98–104
   PubMed Web of Science ®Google Scholar
• Luchette FA, Jenkins WA, Friend LA, Su C, Fischer JE, James JH. Hypoxia is not the sole cause of lactate production during shock. J Trauma 2002; 52: 415–9
   PubMedGoogle Scholar
• Rady MY, Rivers EP, Nowak RM. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996; 14: 218–25
   PubMed Web of Science ®Google Scholar
• Fink MP. Bench-to-bedside review: cytopathic hypoxia. Crit Care 2003; 6: 491–9
   Google Scholar
• Reilly PM, Wilkins KB, Fuh KC, Haglund U, Bulkley GB. The mesenteric hemodynamic response to circulatory shock: an overview. Shock 2001; 15: 329–43
   PubMed Web of Science ®Google Scholar
• Dahn MS, Lange P, Lobdell K, Hans B, Jacobs LA, Mitchell RA. Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 1987; 101: 69–80
   PubMed Web of Science ®Google Scholar
• Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985; 249: G549–56
   PubMed Web of Science ®Google Scholar
• Krishnagopalan S, Kumar A, Parrillo JE. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002; 8: 376–88
   PubMedGoogle Scholar
• Kumar A, Krieger A, Symeoneides S, Parrillo JE. Myocardial dysfunction in septic shock, II: role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth 2001; 15: 485–511
   PubMedGoogle Scholar
• Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999; 27: 1775–80
   PubMedGoogle Scholar
• Metrangolo L, Fiorillo M, Friedman G, Silance PG, Kahn RJ, Novelli GP, et al. Early hemodynamic course of septic shock. Crit Care Med 1995; 23: 1971–5
   PubMed Web of Science ®Google Scholar
• Bernard GR. Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit Care Med 2003; 31(1 Suppl)S85–93
   Google Scholar
• Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin J, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–77
   PubMed Web of Science ®Google Scholar
• Hinshaw LB. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996; 24: 1072–8
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333: 1025–32
   PubMed Web of Science ®Google Scholar
• LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28: 2729–32
   PubMed Web of Science ®Google Scholar
• Singarajah C, Carlson R. A review of the role of blood lactate measurements in the ICU. J Intensive Care Med 1998; 13: 218–28
   Google Scholar
• Friedman G, Berlot G, Kahn RJ, Vincent JL. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995; 23: 1184–93
   PubMed Web of Science ®Google Scholar
• Levy B, Gawalkiewicz P, Vallet B, Briancon S, Nace L, Bollaert PE. Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients. Crit Care Med 2003; 31: 474–80
   PubMed Web of Science ®Google Scholar
• Marik PE. Gastric intramucosal pH. A better predictor of multi-organ dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104: 225–9
   PubMed Web of Science ®Google Scholar
• Marshall JC. Measuring organ dysfunction in the intensive care unit: why and how?. Can J Anaesth 2005; 52: 224–30
   PubMedGoogle Scholar
• Rackow EC, O'Neil P, Astiz ME, Carpati CM. Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 1999; 27: 1225–9
   PubMedGoogle Scholar
• Sharma S, Kumar A. Septic shock, acute respiratory distress syndrome, and multiple organ failure. Curr Opin Pulm Med 2003; 9: 199–209
   PubMed Web of Science ®Google Scholar
• The International Sepsis Forum. Guidelines for the management of severe sepsis and septic shock. Intensive Care Med 2001;27(Suppl 1):S1–134.
   PubMedGoogle Scholar
• Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999;27:639–60.
   PubMedGoogle Scholar
• Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858–73
   PubMed Web of Science ®Google Scholar
• Boldt J, Muller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: is there a difference?. Intensive Care Med 1998; 24: 28–36
   PubMed Web of Science ®Google Scholar
• Webb AR, Tighe D, Moss RF, al-Saady N, Hynd JE, Bennett ED. Advantages of a narrow-range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitis. Crit Care Med 1991; 19: 409–16
   PubMedGoogle Scholar
• Hollenberg SM, Ahrens TS, Astiz ME, Chalfin DB, Dasta JF, Heard SO, et al. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999; 27: 639–60
   PubMedGoogle Scholar
• Shortgen F, Brochard L, Burnham E, Martin GS. Pro/Con clinical debate: hydroxyethylstarches should be avoided in septic patients. Crit Care 2003; 7: 279–81
   PubMedGoogle Scholar
• Boldt J, Heesen M, Müller M. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996; 83: 254–61
   PubMed Web of Science ®Google Scholar
• Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200–10
   PubMed Web of Science ®Google Scholar
• Morisaki H, Bloos F, Keys J, Martin C, Neal A, Sibbald WJ. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 1994; 77: 1507–18
   PubMed Web of Science ®Google Scholar
• Lum H, Siflinger-Birnboim A, Blumenstock F, Malik AB. Serum albumin decreases transendothelial permeability to macromolecules. Microvasc Res 1991; 42: 91–102
   PubMedGoogle Scholar
• Marx G, Cobas Meyer M, Schuerholz T, Vangerow B, Gratz KF, Hecker H, et al. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med 2002; 28: 629–35
   PubMed Web of Science ®Google Scholar
• Margarson MP, Soni NC. Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol 2002; 92: 2139–45
   PubMedGoogle Scholar
• Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomized trials. Br Med J 1998; 316: 961–4
   PubMed Web of Science ®Google Scholar
• Sakka SG, Meier-Hellmann A, Reinhart K. Do fluid administration and reduction in norepinephrine dose improve global and splanchnic haemodynamics?. Br J Anaesth 2000; 84: 758–62
   PubMedGoogle Scholar
• Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409–17
   PubMed Web of Science ®Google Scholar
• De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Crit Care Med 2003; 31: 1659–67
   PubMed Web of Science ®Google Scholar
• Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272: 1354–7
   PubMed Web of Science ®Google Scholar
• De Backer D, Vincent JL. Norepinephrine administration in septic shock: how much is enough?. Crit Care Med 2002; 30: 1398–9
   PubMedGoogle Scholar
• Hannemann L, Reinhart K, Grenzer O, Meier-Hellmann A, Bredle DL. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995; 23: 1962–70
   PubMedGoogle Scholar
• Zhou SX, Qiu HB, Huang YZ, Yang Y, Zheng RQ. Effects of norepinephrine, epinephrine, norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 2002; 23: 654–8
   PubMedGoogle Scholar
• Gregory JS, Bonfiglio MF, Dasta JF, Reilley TE, Townsend MC, Flancbaum L. Experience with phenylepherine as a component of the pharmacologic support of septic shock. Crit Care Med 1991; 19: 1395–400
   PubMedGoogle Scholar
• Kumar A, Parrillo JE. Shock: classification, pathophysiology, and approach to management. Critical care medicine: principles of diagnosis and management, JE Parillo, RP Dellinger. Mosby Publications, St. Louis, MO 2001; 371–420
   Google Scholar
• Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA III. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487–93
   PubMed Web of Science ®Google Scholar
• Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31: 2646–50
   PubMed Web of Science ®Google Scholar
• Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989–1002
   PubMed Web of Science ®Google Scholar
• Landry DW, Levin HR, Gallant EM, Ashton RC, Jr, Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95: 1122–5
   PubMed Web of Science ®Google Scholar
• Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96: 576–82
   PubMed Web of Science ®Google Scholar
• O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359: 1209–10
   PubMed Web of Science ®Google Scholar
• Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 2003; 107: 2313–9
   PubMed Web of Science ®Google Scholar
• Reinelt H, Radermacher P, Kiefer P, Fischer G, Wachter U, Vogt J, et al. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 1999; 27: 325–31
   PubMed Web of Science ®Google Scholar
• Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997; 23: 282–7
   PubMed Web of Science ®Google Scholar
• Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, et al. Effects of epinephrine, norepinephrine or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999; 27: 893–900
   PubMed Web of Science ®Google Scholar
• Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, et al. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002; 71: 381–8
   PubMedGoogle Scholar
• Nevière R, Mathieu D, Chagnon JL, Lebleu N, Wattel F. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996; 154: 1684–8
   PubMed Web of Science ®Google Scholar
• Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock. Crit Care Clin 2000; 16: 251–87
   PubMedGoogle Scholar
• McIntyre LA FD, Herbert PC, Cook DJ, Magder S, Dhingra V, Bell DR., et al. Are delays in the recognition and initial management of patients with severe sepsis associated with hospital mortality? Crit Care Med 2003;31(12 Suppl):A75.
   Google Scholar
• Elliott DC. An evaluation of the end points of resuscitation. J Am Coll Surg 1998; 187: 536–47
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. French ICU Group for Severe Sepsis. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 1995; 274: 968–74
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337: 582–3
   PubMed Web of Science ®Google Scholar
• Annane D, Sébille V, Troché G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283: 1038–45
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317: 654–8
   Google Scholar
• Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997; 337: 1285–92
   PubMed Web of Science ®Google Scholar
• Chadda K, Annane D. The use of corticosteroids in severe sepsis and acute respiratory distress syndrome. Ann Med 2002; 34: 582–9
   PubMedGoogle Scholar
• Bollaert PE, Charpentier C, Levy B, Bebouverie M, Audibert G, Larcan A, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26: 645–50
   PubMed Web of Science ®Google Scholar
• Briegel J, Forst H, Haller M, Scelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27: 723–32
   PubMed Web of Science ®Google Scholar
• Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862–71
   PubMed Web of Science ®Google Scholar
• Esmon CT, Taylor FB, Jr, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66: 160–5
   PubMed Web of Science ®Google Scholar
• Yan SB, Grinnell BW. Recombinant human protein C, protein S, and thrombomodulin as antithrombotics. Perspect Drug Discov Des 1993; 1: 503–20
   Google Scholar
• Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb 1992; 12: 135–45
   PubMed Web of Science ®Google Scholar
• Fourrier F, Chopin C, Goudemand J, Huart JJ, Runge J, Caron C, et al. Double-blind placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104: 882–8
   PubMed Web of Science ®Google Scholar
• Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dal Nogare A, et al. Assessment and safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single blind, dose escalation study. Crit Care Med 2001; 29: 2081–9
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent J-L, Laterre P-F, LaRossa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709
   PubMed Web of Science ®Google Scholar